BRKR
Get informed when a big investor buys or sells
+ FollowOvervalued by 80.8% based on the discounted cash flow analysis.
| Market cap | $9.57 Billion |
|---|---|
| Enterprise Value | $11.58 Billion |
| Dividend Yield | $0.20 (0.32%) |
| Earnings per Share | $-0.15 |
| Beta | 1.29 |
| Outstanding Shares | 152,200,000 |
| P/E Ratio | -262.93 |
|---|---|
| PEG | 1524.99 |
| Price to Sales | 2.29 |
| Price to Book Ratio | 3.14 |
| Enterprise Value to Revenue | 3.35 |
| Enterprise Value to EBIT | 300.87 |
| Enterprise Value to Net Income | -999 |
| Total Debt to Enterprise | 0.19 |
| Debt to Equity | 0.87 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 77.76% |
|---|---|
| Total Calls | 200▼ 99.91% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 2.24%▼ 87.94% |
|---|---|
| Total Invested | $174.40M▼ 96.47% |
| Investors Holding | 119▼ 231.00% |
No data
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable...